
  
    
      
        Background_NNP
        T-_NNP lymphocytes_NNS expressing_VBG the_DT α_NN :_: β_NN T-_NNP cell_NN antigen_NN receptor_NN
        (_( TCR_NNP )_) consist_VBP of_IN two_CD major_JJ subsets_NNS :_: T_NN cells_NNS expressing_VBG the_DT
        CD_NNP 4_CD surface_NN glycoprotein_NN ,_, which_WDT are_VBP restricted_VBN by_IN the_DT major_JJ
        hystocompatibility_NN complex_JJ (_( MHC_NNP )_) class_NN II_NNP proteins_NNS ,_, and_CC CD_NNP 8_CD
        +_NN T_NN cells_NNS ,_, which_WDT interact_NN with_IN antigen_NN presented_VBN by_IN MHC_NNP
        class_NN I_PRP proteins_VBZ [_NN 1_CD ]_NN ._. CD_NNP 4_CD and_CC CD_NNP 8_CD molecules_NNS bind_NN to_TO
        monomorphic_JJ regions_NNS on_IN class_NN II_NNP and_CC class_NN I_PRP MHC_NNP proteins_NNS
        respectively_RB ,_, thereby_RB increasing_VBG the_DT avidity_NN in_IN the_DT
        interaction_NN of_IN the_DT TCR_NNP with_IN antigen_NN presenting_VBG cells_NNS [_NN 2_CD ]_NN
        ._. An_DT intriguing_JJ question_NN concerns_NNS to_TO the_DT mechanism_NN by_IN which_WDT
        selection_NN and_CC tolerance_NN to_TO self-components_JJ is_VBZ mediated_JJ in_IN
        developing_VBG lymphocytes_NNS ._. This_DT is_VBZ particularly_RB relevant_JJ to_TO T_NN
        Lymphocytes_NNP because_IN of_IN their_PRP$ ability_NN to_TO recognize_VB antigen_NN
        only_RB if_IN this_DT is_VBZ associated_VBN with_IN the_DT class_NN I_PRP or_CC the_DT class_NN II_NNP
        MHC_NNP molecules_NNS [_NN 3_CD ]_NN ,_, and_CC also_RB because_IN of_IN the_DT unique_JJ
        selection_NN process_NN which_WDT operates_VBZ within_IN the_DT thymus_JJ during_IN T_NN
        cell_NN development_NN ._. Early_RB during_IN T-_NNP cell_NN development_NN in_IN the_DT
        thymic_JJ cortex_NN ,_, thymocytes_NNS bear_VBP both_DT of_IN the_DT T_NN cell_NN surface_NN
        glycoproteins_NNS CD_NNP 4_CD and_CC CD_NNP 8_CD and_CC express_VB the_DT α_NN and_CC β_NN
        heterodimer_NN of_IN the_DT TCR_NNP [_NN 4_CD ]_NN ._. Compelling_NNP data_NNS have_VBP
        demonstrated_VBN that_IN CD_NNP 4_CD and_CC CD_NNP 8_CD molecules_NNS participate_VBP in_IN the_DT
        selection_NN of_IN MHC_NNP class_NN I_PRP or_CC class_NN II_NNP restricted_VBD T_NN cells_NNS in_IN
        the_DT thymus_JJ ._. It_PRP is_VBZ known_VBN that_IN during_IN clonal_NN selection_NN in_IN the_DT
        thymus_JJ ,_, immature_NN CD_NNP 4_CD ,_, CD_NNP 8_CD double_JJ positive_JJ cells_NNS develop_VBP
        into_IN single_JJ positive_JJ CD_NNP 4_CD or_CC CD_NNP 8_CD cells_NNS according_VBG to_TO the_DT
        relative_JJ affinity_NN of_IN their_PRP$ TCR_NNP to_TO class_NN II_NNP or_CC class_NN I_PRP
        molecules_NNS respectively_RB [_NN 5_CD 6_CD ]_NN ._. These_DT immature_NN T-_NNP cells_NNS are_VBP
        selected_VBN in_IN the_DT thymic_JJ epithelium_NN on_IN the_DT basis_NN of_IN their_PRP$ TCR_NNP
        interaction_NN with_IN either_DT class_NN I_PRP or_CC class_NN II_NNP MHC_NNP molecules_NNS [_NN
        7_CD 8_CD ]_NN ,_, thus_RB generating_NN two_CD mutually_RB exclusive_JJ
        subpopulations_NNS that_WDT are_VBP characterized_VBN by_IN the_DT expression_NN of_IN
        either_DT CD_NNP 4_CD or_CC CD_NNP 8_CD glycoproteins_NNS [_NN 9_CD ]_NN ._. Earlier_JJR studies_NNS in_IN
        the_DT murine_NN system_NN have_VBP demonstrated_VBN that_IN PMA_NNP and_CC cAMP_NN can_MD
        modulate_VBP the_DT expression_NN CD_NNP 4_CD and_CC CD_NNP 8_CD on_IN developing_VBG
        thymocytes_NNS [_NN 10_CD 11_CD 12_CD 13_CD ]_NN ._. In_IN keeping_VBG with_IN these_DT
        findings_NNS ,_, ex_FW vivo_NN experiments_NNS with_IN human_JJ thymocytes_NNS
        previously_RB reported_VBN by_IN our_PRP$ group_NN ,_, revealed_VBD that_IN while_IN
        phorbol_NN esters_NNS can_MD coordinately_RB regulate_VB the_DT transcription_NN
        of_IN α_NN and_CC β_NN TCR_NNP during_IN intrathymic_JJ T_NN cell_NN differentiation_NN [_NN
        14_CD ]_NN ,_, cAMP_NN selectively_RB affected_VBD the_DT transcription_NN of_IN the_DT α_NN
        and_CC δ-_NN TCR_NNP [_NN 15_CD 16_CD ]_NN ._. Together_RB the_DT murine_NN data_NN and_CC our_PRP$ own_JJ
        findings_NNS support_VBP the_DT hypothesis_NNS that_IN in_IN humans_NNS ,_, TCR_NNP
        expression_NN and_CC CD_NNP 4_CD ,_, CD_NNP 8_CD commitment_NN and_CC selection_NN may_MD be_VB
        regulated_VBN by_IN the_DT same_JJ signal-transduction_JJ pathways_NNS ._. Since_IN
        (_( a_DT )_) it_PRP is_VBZ generally_RB accepted_VBN that_IN CD_NNP 4_CD or_CC CD_NNP 8_CD are_VBP physically_RB
        associated_VBN to_TO the_DT TCR_NNP in_IN the_DT course_NN of_IN T_NN cell_NN activation_NN [_NN
        17_CD 18_CD ]_NN and_CC (_( b_SYM )_) it_PRP is_VBZ well_RB known_VBN that_DT mitogen_NN activated_VBN
        protein_NN (_( MAP_NNP )_) kinase_NN signaling_VBG is_VBZ involved_VBN in_IN the_DT selection_NN
        of_IN the_DT T_NN cell_NN repertoire_NN [_NN 19_CD 20_CD ]_NN ,_, the_DT present_JJ study_NN
        further_JJ proposes_VBZ that_IN the_DT PKC_NNP and_CC PKA-mediated_NNP signaling_VBG ,_,
        which_WDT regulates_VBZ TCR_NNP expression_NN ,_, can_MD coordinately_RB modulate_VBP
        the_DT selection_NN of_IN CD_NNP 4_CD +_NN CD_NNP 8_CD -_: and_CC CD_NNP 4_CD -_: CD_NNP 8_CD +_NN T_NN cells_NNS during_IN
        human_JJ intrathymic_JJ differentiation_NN ._.
      
      
        Results_NNS
        The_DT effect_NN of_IN the_DT phorbol_NN ester_NN
        12_CD -_: tetradecanoylphorbol-_NN 13_CD acetate_NN (_( PMA_NNP )_) and_CC exogenous_JJ cAMP_NN
        on_IN the_DT levels_NNS of_IN mRNA_NN encoding_VBG the_DT CD_NNP 4_CD and_CC CD_NNP 8_CD
        glycoproteins_NNS was_VBD examined_VBN in_IN human_JJ thymocytes_NNS ._. Total_JJ
        post-_NN Ficoll_NNP un-fractionated_JJ thymocytes_NNS were_VBD incubated_JJ in_IN
        the_DT presence_NN or_CC the_DT absence_NN of_IN 10_CD nM_NN PMA_NNP and_CC /_NN or_CC 0_CD ._. 1_CD mM_NN cAMP_NN
        +_NN 1_CD mM_NN of_IN the_DT phosphodiesterase_NN inhibitor_NN
        isobutylemthylxnthine_NN (_( IBMX_NNP )_) ._. The_DT fundamental_JJ reasons_NNS for_IN
        the_DT design_NN of_IN our_PRP$ 
        ex-vivo_JJ experiments_NNS are_VBP three-fold_JJ :_:
        (_( a_DT )_) The_DT need_VBP to_TO evaluate_VB intrathymic_JJ differentiation_NN as_RB
        close_JJ as_IN it_PRP could_MD be_VB physically_RB possible_JJ to_TO an_DT 
        in_IN vivo_NN model_NN ;_: (_( b_SYM )_) We_PRP sought_VBD to_TO
        perform_VB the_DT experiments_NNS on_IN "_'' untouched_JJ "_'' cells_NNS with_IN the_DT least_JJS
        of_IN manipulations_NNS ._. In_IN purifying_VBG thymocyte_NN subsets_NNS ,_, there_EX is_VBZ
        a_DT risk_NN that_IN the_DT antibodies_NNS used_VBN for_IN the_DT selection_NN of_IN the_DT DP_NNP
        subset_NN can_MD stimulate_VB cells_NNS through_IN a_DT TCR-like_NNP signaling_VBG ,_,
        thus_RB masking_VBG the_DT read-out_JJ of_IN the_DT experimental_JJ stimuli_NNS and_CC ;_:
        (_( c_SYM )_) At_IN least_JJS 80_CD %_NN of_IN thymocytes_NNS are_VBP double_JJ positive_JJ (_( DP_NNP )_)
        cells_NNS ._. Therefore_RB the_DT contribution_NN of_IN single_JJ positive_JJ (_( SP_NNP )_)
        cannot_NN be_VBP a_DT concern_NN ._. After_IN 3_CD ._. 0_CD h_NN incubation_NN RNA_NNP was_VBD
        extracted_VBN and_CC analyzed_VBN for_IN CD_NNP 4_CD and_CC CD_NNP 8_CD expression_NN by_IN
        northern_JJ blot_NN hybridizations_NNS ._. As_IN shown_VBN in_IN Fig_NNP ._. 1_LS ,_, PMA_NNP
        caused_VBD a_DT marked_VBD decrease_NN in_IN the_DT levels_NNS of_IN both_DT CD_NNP 4_CD and_CC CD_NNP 8_CD
        mRNAs_NNS ,_, whose_WP$ constitutive_JJ expression_NN is_VBZ high_JJ in_IN developing_VBG
        thymocytes_NNS ._. In_IN contrast_NN ,_, cAMP_NN selectively_RB decreased_VBD CD_NNP 8_CD
        mRNA_NN levels_NNS ._. On_IN the_DT other_JJ hand_NN ,_, apoptosis_NNS was_VBD ruled_VBN out_IN as_IN
        a_DT mechanism_NN to_TO explain_VB the_DT differential_NN down-regulation_JJ of_IN
        CD_NNP 4_CD and_CC CD_NNP 8_CD by_IN PMA_NNP and_CC cAMP_NN ,_, on_IN the_DT grounds_NNS of_IN two_CD
        independent_JJ observations_NNS :_: (_( a_DT )_) After_IN a_DT maximum_NN of_IN 4_CD ._. 0_CD hr_NN
        incubation_NN with_IN either_DT PMA_NNP or_CC cAMP_NN +_NN IBMX_NNP the_DT cell_NN viability_NN
        was_VBD the_DT same_JJ as_IN the_DT untreated_JJ controls_NNS (_( usually_RB between_IN
        90_CD -_: 95_CD %_NN )_) ;_: (_( b_SYM )_) Treatment_NNP with_IN dexamethasone_NN ,_, which_WDT is_VBZ a_DT known_VBN
        pro-apoptotic_JJ molecule_NN did_VBD not_RB have_VB any_DT effects_NNS on_IN the_DT
        expression_NN of_IN either_DT CD_NNP 4_CD or_CC CD_NNP 8_CD (_( data_NNS not_RB shown_VBN )_) and_CC ;_: (_( c_SYM )_)
        As_IN demonstrated_VBN earlier_RBR in_IN the_DT murine_NN system_NN ,_, TCR_NNP
        engagement_NN of_IN CD_NNP 4_CD +_NN CD_NNP 8_CD +_NN induces_VBZ positive_JJ selection_NN but_CC not_RB
        apoptosis_NNS [_NN 12_CD ]_NN
        To_TO further_VB investigate_VB whether_IN the_DT effect_NN of_IN PMA_NNP on_IN CD_NNP 4_CD
        and_CC CD_NNP 8_CD expression_NN is_VBZ consistent_JJ with_IN the_DT activation_NN of_IN
        protein_NN kinase_NN C_NNP (_( PKC_NNP )_) ,_, we_PRP examined_VBD structurally_RB distinct_JJ
        phorbol_NN esters_NNS that_IN either_DT have_VBP or_CC lack_NN the_DT capacity_NN to_TO
        activate_VBP PKC_NNP ,_, for_IN their_PRP$ effectiveness_NN to_TO modulate_VBP the_DT
        levels_NNS of_IN CD_NNP 4_CD and_CC CD_NNP 8_CD mRNAs_NNS ._. As_IN shown_VBN in_IN Fig_NNP ._. 2_LS ,_, the_DT
        α-configuration_JJ of_IN the_DT phorbol_NN ester_NN that_WDT lacks_VBZ the_DT ability_NN
        to_TO activate_VBP PKC_NNP [_NN 21_CD ]_NN had_VBD no_DT effect_NN on_IN the_DT expression_NN of_IN
        CD_NNP 4_CD and_CC CD_NNP 8_CD ._. In_IN contrast_NN ,_, the_DT β-configuration_JJ that_WDT has_VBZ the_DT
        capacity_NN to_TO activate_VBP PKC_NNP [_NN 21_CD ]_NN decreased_VBD the_DT levels_NNS of_IN CD_NNP 4_CD
        and_CC CD_NNP 8_CD mRNAs_NNS ._. The_DT water-soluble_JJ phorbol_NN 12_CD ,_, 13_CD dibutyrate_NN
        (_( PDB_NNP )_) had_VBD similar_JJ effects_NNS to_TO those_DT of_IN PMA_NNP ._. The_DT specificity_NN
        of_IN the_DT signals_NNS driven_VBN by_IN PMA_NNP was_VBD further_RBR stressed_VBN by_IN the_DT
        up-regulation_JJ of_IN CD_NNP 3_CD expression_NN and_CC by_IN the_DT unaltered_JJ mRNA_NN
        levels_NNS of_IN the_DT proto-oncogene_JJ c-_NN Ha-ras_NNP ._.
        On_IN the_DT other_JJ hand_NN ,_, it_PRP has_VBZ been_VBN previously_RB demonstrated_VBN
        that_IN direct_JJ activation_NN of_IN adenylate_NN cyclase_NN by_IN Forskolin_NNP or_CC
        cholera_NN toxin_NN ,_, inhibition_NN of_IN cAMP-specific_JJ
        phosphodiesterase_NN ,_, and_CC treatment_NN with_IN a_DT cell_NN permeable_JJ cAMP_NN
        analog_NN ,_, induces_VBZ a_DT rise_NN in_IN intracellular_NN cAMP_NN [_NN 22_CD 23_CD 24_CD 25_CD
        26_CD ]_NN ._. Since_IN cAMP_NN is_VBZ known_VBN to_TO modulate_VBP the_DT expression_NN of_IN
        CD_NNP 8_CD in_IN mice_NNS [_NN 27_CD ]_NN ,_, we_PRP sought_VBD to_TO determine_VB whether_IN
        cAMP-dependent_JJ protein_NN kinase_NN (_( PKA_NNP )_) -_: mediated_JJ signaling_VBG
        plays_VBZ a_DT role_NN in_IN modulating_VBG the_DT mRNA_NN levels_NNS of_IN CD_NNP 3_CD ,_, CD_NNP 4_CD ,_, and_CC
        CD_NNP 8_CD in_IN ex_FW vivo_NN examined_VBD human_JJ thymocytes_NNS ._. Fig_NNP ._. 3_LS shows_VBZ that_IN
        the_DT signal_NN ,_, which_WDT regulates_VBZ the_DT expression_NN of_IN human_JJ CD_NNP 8_CD ,_, is_VBZ
        cAMP-mediated_JJ ,_, since_IN direct_JJ activation_NN of_IN adenylate_NN cyclase_NN
        by_IN cholera_NN toxin_NN produced_VBD the_DT same_JJ effects_NNS as_IN the_DT
        di-butiryl_JJ cAMP_NN analog_NN ._. The_DT requirement_NN of_IN
        phosphodiesterase_NN inhibition_NN by_IN IBMX_NNP further_JJ supports_VBZ this_DT
        statement_NN ._. As_IN it_PRP can_MD also_RB be_VB observed_VBN ,_, cAMP_NN coordinately_RB
        regulated_VBN the_DT expression_NN of_IN both_DT the_DT α_NN and_CC β_NN chains_NNS of_IN the_DT
        CD_NNP 8_CD molecule_NN ._. CD_NNP 4_CD remained_VBD unchanged_JJ and_CC CD_NNP 3_CD was_VBD minimally_RB
        affected_VBN ,_, thus_RB stressing_VBG the_DT selectivity_NN of_IN the_DT
        cAMP-dependent_JJ down-regulation_JJ of_IN CD_NNP 8_CD expression_NN (_( Fig_NNP ._. 3_LS )_) ._.
        To_TO further_VB investigate_VB whether_IN PMA_NNP and_CC cAMP_NN regulate_VB CD_NNP 4_CD
        and_CC CD_NNP 8_CD expression_NN at_IN the_DT protein_NN level_NN ,_, surface_NN detection_NN
        of_IN the_DT CD_NNP 3_CD ,_, CD_NNP 4_CD ,_, and_CC CD_NNP 8_CD was_VBD also_RB assessed_VBN ._. As_IN observed_VBD in_IN
        Fig_NNP ._. 4_LS aPMA_NN dropped_VBD the_DT proportion_NN of_IN CD_NNP 4_CD +_NN cells_NNS from_IN 60_CD %_NN to_TO
        zero_CD ,_, produced_VBD a_DT slight_JJ decrease_NN (_( from_IN 71_CD %_NN to_TO 64_CD %_NN )_) in_IN CD_NNP 8_CD
        +_NN cells_NNS ,_, and_CC did_VBD not_RB affect_VB the_DT expression_NN of_IN CD_NNP 3_CD ._. cAMP_NN on_IN
        the_DT other_JJ hand_NN had_VBD little_JJ effect_NN on_IN the_DT surface_NN expression_NN
        of_IN the_DT glycoproteins_NNS ._. These_DT findings_NNS are_VBP in_IN contrast_NN with_IN
        the_DT drastic_JJ down-regulation_JJ of_IN CD_NNP 8_CD transcript_NN levels_NNS
        exerted_VBN by_IN cAMP_NN ._. However_RB ,_, regulation_NN gene_NN expression_NN is_VBZ
        complex_JJ and_CC engages_VBZ numerous_JJ checkpoints_NNS that_WDT include_VBP
        transcription_NN ,_, RNA_NNP processing_NN ,_, nuclear_JJ /_NN cytosol_NN transport_NN ,_,
        translation_NN ,_, and_CC RNA_NNP and_CC Protein_NNP stability_NN ._. Since_IN the_DT
        half-lives_JJ of_IN mRNA_NN and_CC protein_NN can_MD be_VB dramatically_RB
        different_JJ ,_, we_PRP hypothesize_NN that_IN an_DT increased_VBN CD_NNP 8_CD protein_NN
        stability_NN may_MD result_VB in_IN a_DT delay_NN of_IN CD_NNP 8_CD surface_NN
        disappearance_NN ,_, thus_RB favoring_VBG its_PRP$ transient_JJ selection_NN ._. As_IN
        CD_NNP 8_CD gene_NN transcription_NN has_VBZ been_VBN turned-off_JJ by_IN cAMP-mediated_JJ
        signaling_VBG ,_, surface_NN CD_NNP 8_CD subsequently_RB fades_NNS with_IN the_DT
        concomitant_NN emergence_NN of_IN CD_NNP 4_CD +_NN cells_NNS ._. In_IN keeping_VBG with_IN this_DT
        rationale_NN ,_, the_DT kinetics_NNS of_IN the_DT PMA-mediated_NNP down-regulation_JJ
        of_IN CD_NNP 4_CD (_( Fig_NNP ._. 4_LS b_SYM )_) reveals_VBZ a_DT sharp_JJ and_CC rapid_JJ decrease_NN on_IN CD_NNP 4_CD
        surface_NN expression_NN as_RB early_RB as_IN 15_CD min_NN ._. of_IN incubation_NN with_IN
        PMA_NNP ,_, with_IN a_DT complete_JJ disappearance_NN by_IN 2_CD ._. 0_CD hr_NN ._. The_DT
        relatively_RB short_JJ kinetics_NNS of_IN surface_NN CD_NNP 4_CD down-regulation_JJ
        and_CC the_DT delayed_VBN CD_NNP 8_CD surface_NN disappearance_NN can_MD be_VB
        interpreted_VBN as_IN a_DT PKC-mediated_NNP selection_NN signaling_VBG in_IN favor_NN
        of_IN CD_NNP 8_CD +_NN CD_NNP 4_CD -_: /_NN α_NN :_: β-_NN TCR_NNP cells_NNS that_WDT may_MD operate_VB during_IN
        intrathymic_JJ T_NN cell_NN differentiation_NN ._. Binding_NNP of_IN specific_JJ
        ligands_NNS to_TO CD_NNP 4_CD (_( including_VBG phorbol_NN esters_NNS )_) results_NNS in_IN
        internalization_NN of_IN the_DT molecule_NN by_IN endocytosis_NNS ,_, which_WDT in_IN
        turn_NN is_VBZ phosphorylated_JJ [_NN 28_CD ]_NN and_CC possibly_RB immobilized_JJ ._. It_PRP
        is_VBZ conceivable_JJ that_IN a_DT similar_JJ mechanism_NN might_MD be_VB used_VBN by_IN
        extra-cellular_JJ signals_NNS in_IN the_DT thymic_JJ epithelium_NN during_IN
        intrathymic_JJ differentiation_NN ._.
      
      
        Discussion_NNP
        An_DT accepted_VBN scheme_NN of_IN the_DT T_NN cell_NN development_NN program_NN [_NN
        29_CD 30_CD ]_NN has_VBZ demonstrated_VBN that_IN as_IN immature_NN cells_NNS enter_VBP the_DT
        thymus_JJ ,_, cycling_NN CD_NNP 4_CD -_: CD_NNP 8_CD -_: precursors_NNS begin_VBP to_TO rearrange_VB δ_NN ,_,
        and_CC γ_NN genes_NNS ,_, which_WDT generates_VBZ CD_NNP 4_CD -_: CD_NNP 8_CD -_: ,_, and_CC δ_NN +_NN γ_NN +_NN cells_NNS ._.
        CD_NNP 4_CD +_NN CD_NNP 8_CD +_NN on_IN the_DT other_JJ hand_NN ,_, rearrange_VB and_CC express_VB the_DT
        α_NN :_: β-_NN TCR_NNP heterodimer_NN ._. A_DT few_JJ of_IN these_DT cells_NNS are_VBP selected_VBN
        through_IN the_DT specificity_NN of_IN their_PRP$ antigen_NN receptor_NN and_CC
        mature_VBP into_IN either_DT CD_NNP 4_CD +_NN CD_NNP 8_CD -_: ,_, or_CC CD_NNP 4_CD -_: CD_NNP 8_CD +_NN T_NN cells_NNS which_WDT
        exit_NN from_IN the_DT thymus_JJ ._.
        Much_JJ progress_NN has_VBZ been_VBN accomplished_VBN in_IN determining_VBG the_DT
        molecular_JJ steps_NNS that_WDT lead_VBP to_TO a_DT better_JJR understanding_NN of_IN
        murine_NN T_NN cell_NN progenitor_NN commitment_NN and_CC selection_NN of_IN the_DT
        functional_JJ repertoire_NN ,_, which_WDT has_VBZ gained_VBN important_JJ insights_NNS
        into_IN mechanisms_NNS of_IN CD_NNP 4_CD /_NN CD_NNP 8_CD lineage_NN commitment_NN (_( reviewed_VBN in_IN
        31_CD )_) ._. For_IN instance_NN ,_, changes_NNS in_IN expression_NN of_IN CD_NNP 5_CD ,_, TCR_NNP ,_,
        Bcl-_NNP 2_CD ,_, RAG_NNP and_CC TdT_NNP genes_NNS can_MD be_VB induced_VBN by_IN in_IN vitro_NN TCR_NNP
        engagement_NN of_IN DP_NNP thymocytes_NNS ,_, thus_RB indicating_VBG that_IN at_IN least_JJS
        some_DT aspects_NNS in_IN the_DT T_NN cell_NN maturation_NN program_NN are_VBP directly_RB
        coupled_VBN to_TO TCR_NNP signaling_VBG ._. It_PRP is_VBZ therefore_RB accepted_VBN that_IN
        positive_JJ selection_NN are_VBP directly_RB coupled_VBN to_TO TCR_NNP signaling_VBG
        pathways_NNS in_IN DP_NNP thymocytes_NNS ._. However_RB ,_, the_DT signals_NNS that_WDT
        promote_VBP selective_JJ down_RB regulation_NN of_IN CD_NNP 4_CD and_CC CD_NNP 8_CD remain_VB
        have_VBP not_RB been_VBN that_IN conclusive_JJ ,_, at_IN least_JJS in_IN humans_NNS ._. Earlier_RBR
        (_( again_RB murine_NN )_) studies_NNS (_( reviewed_VBN in_IN 31_CD )_) have_VBP suggested_VBN that_IN
        a_DT transitional_JJ phenotype_NN of_IN CD_NNP 4_CD +_NN CD_NNP 8_CD lowis_NNS not_RB a_DT signature_NN
        of_IN commitment_NN towards_IN the_DT CD_NNP 4_CD lineage_NN ._. The_DT confirmation_NN of_IN
        such_JJ conclusion_NN in_IN the_DT humans_NNS and_CC the_DT determination_NN of_IN the_DT
        signals_NNS that_WDT lead_VBP to_TO the_DT phenotype_NN remain_VB to_TO be_VB
        assessed_VBN ._.
        We_PRP have_VBP previously_RB shown_VBN that_IN PMA_NNP strongly_RB induces_VBZ the_DT
        transcription_NN of_IN α_NN and_CC β_NN TCR_NNP in_IN human_JJ thymocytes_NNS ,_, whereas_IN
        cAMP_NN exclusively_RB affected_VBD the_DT transcription_NN of_IN α-_NN TCR_NNP [_NN 15_CD
        16_CD ]_NN ._. The_DT data_NNS reported_VBD herein_NN ,_, suggest_VBP that_IN following_VBG
        rearrangement_NN ,_, protein_NN kinase_NN C_NNP activation_NN mimicked_JJ by_IN the_DT
        phorbol_NN esters_NNS induces_VBZ the_DT expression_NN of_IN the_DT α_NN and_CC β-_NN TCR_NNP on_IN
        CD_NNP 4_CD +_NN CD_NNP 8_CD +_NN precursor_NN T_NN cells_NNS ._. Since_IN only_RB a_DT proportion_NN of_IN
        developing_VBG thymocytes_NNS succeed_VBP in_IN expressing_VBG the_DT α_NN :_: β_NN TCR_NNP
        heterodimer_NN ,_, PKC_NNP activation_NN also_RB provides_VBZ the_DT signal_NN to_TO
        turning_VBG off_IN the_DT CD_NNP 4_CD and_CC CD_NNP 8_CD genes_NNS on_IN cells_NNS that_WDT failed_VBD to_TO
        express_VB the_DT TCR_NNP ,_, which_WDT are_VBP non-functional_JJ and_CC potentially_RB
        harmful_JJ ._. On_IN the_DT other_JJ hand_NN ,_, cAMP_NN is_VBZ known_VBN to_TO participate_VB in_IN
        the_DT growth_NN and_CC differentiation_NN of_IN varied_JJ cell_NN types_NNS
        (_( including_VBG thymocytes_NNS )_) ,_, through_IN the_DT transcriptional_NN
        regulation_NN of_IN specific_JJ genes_NNS [_NN 32_CD 33_CD 34_CD ]_NN ._. The_DT unique_JJ cAMP_NN
        signaling_VBG which_WDT specifically_RB targets_VBZ the_DT expression_NN of_IN the_DT
        CD_NNP 8_CD mRNAs_NNS (_( α_NN and_CC β_NN )_) ,_, suggests_VBZ that_IN PKA_NNP activation_NN may_MD
        result_VB in_IN the_DT transduction_NN of_IN signals_NNS that_WDT determine_VBP the_DT
        selection_NN of_IN T_NN lymphocytes_NNS in_IN favor_NN of_IN the_DT CD_NNP 4_CD +_NN CD_NNP 8_CD
        -_: lineage_NN ,_, by_IN down-regulating_JJ and_CC possibly_RB turning_VBG off_IN the_DT
        expression_NN of_IN the_DT CD_NNP 8_CD transcripts_NNS ._. In_IN keeping_VBG with_IN this_DT
        notion_NN ,_, regulatory_JJ elements_NNS ,_, within_IN the_DT CD_NNP 4_CD and_CC CD_NNP 8_CD
        promoters_NNS have_VBP been_VBN identified_VBN an_DT characterized_VBN including_VBG
        the_DT presence_NN of_IN cAMP_NN regulatory_JJ elements_NNS binding_JJ (_( CREB_NNP )_)
        sites_NNS [_NN 35_CD ]_NN ._. However_RB it_PRP is_VBZ also_RB likely_JJ that_IN the_DT control_NN
        of_IN CD_NNP 4_CD and_CC CD_NNP 8_CD expression_NN and_CC thus_RB the_DT selection_NN of_IN CD_NNP 4_CD or_CC
        CD_NNP 8_CD lineage-committed_JJ cells_NNS may_MD also_RB be_VB controlled_VBN by_IN the_DT
        differences_NNS in_IN mRNA_NN and_CC protein_NN stability_NN ._. Lastly_NNP ,_, some_DT of_IN
        the_DT TCR_NNP signaling_VBG pathways_NNS involved_VBN in_IN positive_JJ selection_NN
        have_VBP been_VBN identified_VBN in_IN the_DT mouse_NN and_CC there_EX is_VBZ some_DT
        evidence_NN that_IN these_DT may_MD be_VB different_JJ from_IN those_DT involved_VBN in_IN
        negative_JJ selection_NN ._. It_PRP remains_VBZ to_TO be_VB determined_VBN whether_IN
        same_JJ interpretation_NN applies_VBZ to_TO human_JJ T_NN cell_NN selection_NN ._.
      
      
        Conclusion_NNP
        In_IN conclusion_NN ,_, the_DT results_NNS of_IN the_DT ex_FW vivo_NN experiments_NNS of_IN
        human_JJ thymocytes_NNS reported_VBD in_IN the_DT present_JJ study_NN are_VBP in_IN
        complete_JJ agreement_NN with_IN the_DT earlier_JJR studies_NNS in_IN the_DT murine_NN
        system_NN and_CC strongly_RB support_VB the_DT conclusions_NNS ._. We_PRP further_JJ
        propose_VB that_IN the_DT transduction_NN of_IN intracellular_NN signals_NNS
        initiated_VBN by_IN the_DT activation_NN of_IN PKC_NNP and_CC PKA_NNP by_IN phorbol_NN
        esters_NNS and_CC cAMP_NN respectively_RB ,_, are_VBP not_RB only_RB critical_JJ for_IN the_DT
        differential_NN regulation_NN of_IN CD_NNP 4_CD and_CC CD_NNP 8_CD gene_NN expression_NN but_CC
        more_RBR importantly_RB in_IN the_DT commitment_NN and_CC selection_NN of_IN the_DT
        functional_JJ T_NN cell_NN repertoire_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Cells_NNP
          Human_JJ thymocytes_NNS were_VBD purified_JJ from_IN fresh_JJ residual_JJ
          thymic_JJ tissue_NN that_WDT was_VBD obtained_VBN as_IN an_DT incidental_JJ specimen_NN
          from_IN immunologially_RB normal_JJ pediatric_JJ patients_NNS undergoing_VBG
          cardiac_JJ surgery_NN and_CC according_VBG with_IN institutional_JJ
          guidelines_NNS ._. Purification_NNP was_VBD carried_VBN out_IN by_IN a_DT single_JJ step_NN
          Ficoll_NNP /_NN Hypaque_NNP gradient_NN centrifugation_NN ._. Purified_NNP cells_NNS
          were_VBD cultured_JJ at_IN 37_CD °_NN C_NNP in_IN RPMI-_NNP 1640_CD medium_NN supplemented_JJ
          with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN at_IN a_DT density_NN of_IN 5_CD ×_NN 10_CD
          6_CD cells_NNS /_NN ml_NN and_CC in_IN the_DT presence_NN or_CC absence_NN of_IN 10_CD nM_NN PMA_NNP
          phorbol_NN ester_NN and_CC or_CC 1_CD mM_NN dibutyryl_NN cAMP_NN +_NN 1_CD mM_NN
          phosphodiesterase_NN inhibitor_NN isobutylemthylxnthine_NN
          (_( IMBX_NNP )_) ._.
        
        
          Reagents_NNP
          The_DT phorbol_NN esters_NNS 12_CD -_: tetradecanoylphorbol-_NN 13_CD acetate_NN
          (_( PMA_NNP )_) ,_, 4_CD x-phorbol_JJ ,_, 12_CD ,_, 13_CD didecanoate_NN (_( αPD_NN 2_LS )_) ,_, 4_CD B-_NNP phorbol_NN
          12_CD ,_, 13_CD didecanoate_NN (_( βPD_NN 2_LS )_) ,_, the_DT phorbol_NN 12_CD ,_, 13_CD dibutyrate_NN
          (_( PDB_NNP )_) ,_, dibutyryl_NN cyclic_JJ AMP_NNP ,_, and_CC the_DT IBMX_NNP were_VBD obtained_VBN
          from_IN Sigma_NNP Chemical_NNP Co_NNP ._. (_( St_NNP ._. Louis_NNP ,_, MO_NNP ._. )_) ._. Deionized_NNP
          formamide_NN Distilled_NNP Phenol_NNP and_CC guanidinium_NN isothiocyanate_NN
          were_VBD purchased_VBN from_IN Fluka_NNP (_( Milwaukee_NNP ,_, Wl_NNP )_) ._. Nylon_NNP Hybond_NNP
          membranes_NNS (_( 0_CD ._. 45_CD mm_NN )_) ,_, and_CC 32_CD p-d_JJ CTP_NNP were_VBD obtained_VBN from_IN
          Amersham_NNP (_( Arlington_NNP Heights_NNP ,_, IL_NNP )_) ._. The_DT CD_NNP 3_CD plasmid_NN was_VBD
          commercially_RB obtained_VBN from_IN the_DT American_NNP Type_NNP Culture_NNP
          Collection_NNP (_( ATCC_NNP ,_, Manassas_NNP ,_, VA_NNP )_) and_CC the_DT respective_JJ cDNA_NN
          insert_NN was_VBD generated_VBN by_IN a_DT Pst_NNP I_PRP digestion_NN ._. CD_NNP 4_CD [_NN 36_CD ]_NN and_CC
          CD_NNP 8_CD [_NN 37_CD ]_NN were_VBD kind_NN gifts_NNS from_IN Dr_NNP ._. Dan_NNP Littman_NNP and_CC the_DT
          respective_JJ cDNA_NN probes_NNS were_VBD obtained_VBN by_IN digestion_NN with_IN
          the_DT EcoR_NNP 1_CD restriction_NN endonuclease_NN ._. The_DT cHa-ras_JJ was_VBD also_RB
          from_IN ATCC_NNP and_CC the_DT respective_JJ insert_NN probe_NN was_VBD excised_VBN by_IN
          a_DT Barn_NNP H_NNP 1_CD endonuclease_NN digestion_NN ._. The_DT monoclonal_NN
          antibodies_NNS to_TO CD_NNP 3_CD ,_, CD_NNP 4_CD ,_, and_CC CD_NNP 8_CD were_VBD commercially_RB
          obtained_VBN (_( Pharmigen_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ._.
        
        
          RNA_NNP Extraction_NNP
          Total_JJ unfractionated_JJ RNA_NNP was_VBD extracted_VBN in_IN guanidiniun_NN
          isothiocyanate_NN as_RB previously_RB described_VBD [_NN 38_CD ]_NN ._.
        
        
          Northern_NNP Blots_NNP
          Total_NNP RNA_NNP (_( 10_CD μg_NN )_) was_VBD electrophoresed_JJ in_IN 1_CD ._. 0_CD %_NN agarose_NN
          gel_NN and_CC transferred_VBN onto_IN nylon_NN membranes_NNS as_IN described_VBN
          earlier_JJR [_NN 39_CD ,_, 40_CD ]_NN ._. Blots_NNP were_VBD then_RB prehybridized_JJ overnight_JJ
          at_IN 42_CD °_NN C_NNP in_IN 50_CD %_NN formamide_NN ,_, 4_CD X_NNP SSC_NNP ,_, 5_CD X_NNP Denhart_NNP 's_POS solution_NN ,_,
          25_CD mM_NN sodium_NN phosphate_NN ,_, pH_NN 6_CD ._. 5_CD ,_, 1_CD ._. 0_CD %_NN sodium_NN deodecyi_NN
          sulphate_NN (_( SDS_NNP )_) ,_, and_CC 200_CD μg_NN /_NN ml_NN salmon_NN sperm_NN DNA_NNP ._.
          Hybridization_NNP was_VBD carried_VBN out_IN for_IN 16_CD hr_NN ._. at_IN 42_CD °_NN C_NNP ,_, simply_RB
          by_IN adding_VBG [_NN a-_NN 32_CD P_NN ]_NN dCTP-labeled_JJ probes_NNS ._. After_IN
          hybridization_NN ,_, northern_JJ blots_NNS were_VBD stringently_RB washed_VBN for_IN
          2_CD ._. 0_CD hr_NN ._. and_CC autoradiographed_JJ ._. Equal_NNP amounts_NNS of_IN RNA_NNP
          loading_NN of_IN the_DT different_JJ experimental_JJ samples_NNS ,_, was_VBD
          confirmed_VBN by_IN ethidium_NN bromide_NN staining_VBG and_CC ultraviolet_NN
          transilluminator_NN visualization_NN ._. The_DT constitutively_RB
          expressed_VBN proto-oncogene_JJ c-_NN Ha-ras_NNP was_VBD used_VBN as_IN internal_JJ
          control_NN ._.
        
        
          Immunofluorescent_NNP Staining_NNP
          Freshly_NNP isolated_VBD thymocytes_NNS were_VBD incubated_JJ in_IN the_DT
          presence_NN or_CC the_DT absence_NN of_IN either_DT PMA_NNP or_CC cAMP_NN +_NN IBMX_NNP ._. At_IN
          the_DT indicated_VBN times_NNS cells_NNS were_VBD harvested_VBN ,_, washed_VBD twice_RB
          with_IN phosphate-buffered_JJ saline_NN (_( containing_VBG 0_CD ._. 1_CD %_NN serum_NN
          bovine_JJ albumin_NN and_CC 0_CD ._. 1_CD %_NN sodium_NN azide_NN )_) ,_, and_CC incubated_JJ for_IN
          30_CD min_NN at_IN 4_CD °_NN C_NNP with_IN specific_JJ monoclonal_NN antibodies_NNS to_TO
          either_CC CD_NNP 3_CD ,_, CD_NNP 4_CD or_CC CD_NNP 8_CD ._. Cells_NNP were_VBD then_RB washed_VBN twice_RB with_IN
          PBS_NNP and_CC incubated_JJ for_IN 30_CD min_NN at_IN 4_CD °_NN C_NNP with_IN the_DT appropriate_JJ
          FITC-conjugated_NNP second_JJ antibody_NN ._. After_IN the_DT second_JJ
          incubation_NN the_DT cells_NNS were_VBD washed_VBN twice_RB with_IN PBS_NNP and_CC
          analyzed_VBD on_IN a_DT fluorescence-activated_JJ Cell_NNP Sorter_NNP (_( FACS_NNP )_)
          II_NNP ._.
        
      
      
        List_NN of_IN Abbreviations_NNP
        IBMX_NNP :_: isobutylemthylxnthine_NN /_NN PMA_NNP :_:
        12_CD -_: tetradecanoylphorboMS_NN acetate_NN /_NN PKA_NNP :_: cAMP-dependent_JJ
        Protein_NNP Kinase_NNP /_NN PKC_NNP :_: Protein_NNP Kinase_NNP C_NNP
      
    
  
